Monitoring real-life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry.

Fábio Cardoso BorgesCatarina RamosAdriana RamosGonçalo P MendesRodrigo MurteiraPatrícia SoaresClaudia FurtadoAna C MirandaFilipa Alves da Costanull null

Published in: Pharmacoepidemiology and drug safety (2020)

Our data suggest lower effectiveness in a real-life context than the efficacy reported in the clinical trial. Safety data seems, however, quite comparable to KEYNOTE-006.

Keyphrases

clinical trial
electronic health record
big data
phase ii
systematic review
open label
study protocol
advanced non small cell lung cancer
data analysis
phase iii
epidermal growth factor receptor